Morristown, NJ, United States of America

Richard D'Souza

USPTO Granted Patents = 12 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
12 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Richard D'Souza in Parkinson's Disease Treatment**

Introduction

Richard D'Souza, an accomplished inventor based in Morristown, NJ, has made significant contributions to the field of pharmaceuticals, particularly focusing on the treatment of Parkinson's disease. With an impressive portfolio of 9 patents, his work is pivotal in enhancing the quality of life for patients affected by this debilitating condition.

Latest Patents

Among Richard D'Souza's latest innovations are groundbreaking patents related to levodopa dosing regimens aimed at treating patients with Parkinson's disease. One notable invention involves a method for treating levodopa naïve patients. This method entails the oral administration of a controlled release levodopa formulation twice daily, leading to marked improvements in the patient's motor state, as reflected in their Parkinson's disease diary. It claims a reduction in tremors, dyskinesia, and mobility issues by approximately 10%-40%. Additionally, it aims to decrease the Movement Disorders Society version of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) scores by at least 3 points.

Another impactful patent focuses on a method for managing patients already diagnosed with Parkinson's disease, employing a controlled release levodopa formulation. This regimen is designed to significantly enhance the patient's total post-dose 'Off' time, total post-dose “On” time, and overall “Good On” time compared to traditional immediate release levodopa tablets.

Career Highlights

Richard D'Souza is currently associated with Amneal Pharmaceuticals LLC, where he continues to explore innovative treatments for neurodegenerative disorders. His decade-spanning career is characterized by a commitment to advancing pharmacological therapies, reflecting his deep understanding of patient needs and responsive treatment strategies.

Collaborations

Richard collaborates closely with industry professionals such as Hester Visser and Suneel Gupta. These partnerships emphasize the importance of teamwork in the realm of pharmaceutical research and development, driving the quest for innovative solutions in treating complex medical conditions.

Conclusion

In conclusion, Richard D'Souza stands out as a prominent inventor in the pharmaceutical sector, particularly noted for his advancements in Parkinson's disease treatments. His innovative approaches, evidenced by his patents, demonstrate a blend of scientific ingenuity and a compassion for improving patient outcomes. As the landscape of medicine continues to evolve, Richard's work promises to bring hope and enhanced quality of life to many individuals battling Parkinson's disease.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…